Onco-Hu mouse models for cancer research

8 April 2024

Mouse models serve as essential tools for studying tumor development, progression, and response to therapies. Genetically engineered mice can mimic human cancer mutations, allowing researchers to investigate the molecular mechanisms underlying cancer initiation and progression. Dr. Brian Soper from The Jackson Laboratory explores Onco-Hu® models, a robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells. The platform is based on NSG™ and NSG™-SGM3 transgenic mice, dually engrafted with human CD34+ hematopoietic stem cells (HSCs) and clinically relevant PDX Live™ low passage tumors.